Learn more

AMEZCUA AMEZCUA FEDERICO

Overview
  • Total Patents
    23
  • GoodIP Patent Rank
    70,637
About

AMEZCUA AMEZCUA FEDERICO has a total of 23 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and Colombia. Its main competitors in its focus markets pharmaceuticals are MOLECULAR AND CLINICAL DRUG RE, AIRES PHARMACEUTICALS INC and GENOVATE BIOTECHNOLOGY CO LTD.

Patent filings per year

Chart showing AMEZCUA AMEZCUA FEDERICOs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals

Focus technologies

Top inventors

# Name Total Patents
#1 García Armenta Patricia Del Carmen 15
#2 Garcia Armenta Patricia Del Carmen 7
#3 Chávez García José Alonso 4
#4 Chavez Garcia Jose Alonso 2
#5 Chavez García José Alonso 1
#6 Amezcua Amezcua Federico 1
#7 Del Carmen Garcia Armenta Patricia 1
#8 Chavez García Jose Alonso 1

Latest patents

Publication Filing date Title
WO2021010812A1 Synergistic combination of s-ketorolac and pregabalin in a pharmaceutical composition for the treatment of neuropathic pain
WO2020145811A1 Synergic pharmaceutical composition of aceclofenac and betamethasone for treating the pain of rheumatic conditions or postsurgical pain
WO2020096441A1 Pharmaceutical composition which comprises the combination of a selective inhibitor of cyclooxygenase 2 and a carbamate derived from guaifenesin for treating pain, inflammation and muscular contraction
CA3113220A1 Synergic pharmaceutical combination of a leukotriene-receptor antagonist and an inverse agonist of histamine h1
CA3109212A1 Synergistic drug combination of a selective cyclooxygenase-2 inhibitor and a anthraquinone derivative
CA3108680A1 Sinergic pharmaceutical composition of aceclofenac and betamethasone for the treatment of pain in localized forms of rheumatic conditions
WO2020009560A1 Synergic pharmaceutical composition of the active enantiomer (s)-ketorolac and gabapentin for the treatment of neuropathic pain
US2021069151A1 Synergistic pharmaceutical combination of the active enantiomer s-ketorolac tromethamine and tramadol chlorhydrate
EP3725312A1 New chemical compound containing active enantiomer s-(-) ketorolac tromethamine for the treatment of pain